SLC4A1 and metabolic dysfunction-associated steatohepatitis: To benchmark these results in relation to other preclinical models of NAFLD/NASH (WD1, WD2, DIAMOND), the similarity of the animal models to the human dataset (GSE126848) was compared by investigating the comparability of enriched pathways.